Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. - Furlan,A.J.; Eyding,D.; Albers,G.W. (Stroke, 2006)